Canada markets open in 6 hours 37 minutes

Midatech Pharma plc (MTP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7399-0.0001 (-0.01%)
At close: 03:46PM EDT
0.7857 +0.05 (+6.19%)
After hours: 07:06PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.7400
Open0.7400
Bid0.0000 x 1800
Ask0.0000 x 1100
Day's Range0.7100 - 0.7400
52 Week Range0.3800 - 1.9200
Volume65,948
Avg. Volume212,196
Market Cap14.575M
Beta (5Y Monthly)1.55
PE Ratio (TTM)N/A
EPS (TTM)-0.4150
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma

    Orphan Designation Granted by EMA to MTX110 Development for the Treatment of GliomaABINGDON, NR / ACCESSWIRE / June 21, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce that following the submission of an application to the European Medicines Agency ("EMA"), its development programme of MTX110 for the treatment of glioma has been granted Orphan Medicinal Product designa

  • ACCESSWIRE

    Midatech Pharma PLC Announces Directorate Change

    ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 20, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce the appointment of Dr Stephen Parker as a Director of the Company and Non-Executive Chairman of the Board with immediate effect.

  • ACCESSWIRE

    Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman

    ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces that Rolf Stahel, Chairman and non-executive director, intends to retire after the Company's Annual General Meeting on 20 June 2022 ("AGM").